Cantel Medical Corp.
Cantel Medical Corp.'s Medivators Group Gains FDA 510(k) Approval for Its Advantage(TM) Plus Endoscope Reprocessing System
Published in Health Risk Factor Week, March 17th, 2009
CANTEL MEDICAL CORP. (NYSE:CMN) announced that the FDA has cleared its Medivators Advantage Plus Endoscope Reprocessing System and new Rapicide(R) PA High Level Disinfectant for sale in the United States. The Advantage Plus System, with its accompanying new chemistry, represents the latest in a long line of "state of the art", innovative reprocessing technologies that Medivators has been delivering to hospitals and stand-alone GI centers for over 20 years.
Andrew Krakauer, Cantel Medical's President stated, "We are very pleased to have broadened our regulatory approvals and can now sell the full Advantage Series in the United States. The Advantage Plus, together with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Achaogen
Achaogen Signs $26.6 Million Contract With NIAID for Development of New Therapy to Treat Resistant Strains of NIAID Category a and B Priority Pathogens - Aspergillosis
Research by L. Gil and colleagues in aspergillosis provides new insights - Aspergillosis Therapy
Research from University of Lille, Institute Pasteur has provided new information about aspergillosis therapy - AutoVirt, Inc
AutoVirt Launches AutoMap - Site Survey Tool - Bacterial Meningitis
Research from J. Gerber and co-researchers provides new data on bacterial meningitis - Bavarian Nordic A/S
Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE With the FDA After Successful End of Phase II Meeting - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
